Abstract:Fibrillogenesis of amyloid beta-protein (A beta) has been thought to be implicated in the progression of Alzheimer's disease (AD). Therefore, development of high-efficiency inhibitors is one of the strategies for the prevention and treatment of AD. Serum albumin has been found to capture A beta monomers through its hydrophobic groove and suppress amyloid formation, but the inhibition efficiency is limited. Inspired by the strong inhibition potency of a basic protein, human lysozyme, we have herein proposed to develop a basified serum albumin by converting carboxyl groups into amino groups with ethylenediamine conjugated on the protein surface. The idea was verified with both bovine and human serum albumins (BSA/HSA). Four basified BSA (BSA-B) preparations with amino modification degrees (MDs) from 8.0 to 41.5 were first synthesized. Extensive biophysical and biological analyses revealed that the inhibition potency significantly increased with increasing amino MD. BSA-B of the highest MD (41.5), BSA-B4, which had an isoelectric point of 9.7, presented strong inhibition on A beta(42) fibrillation at a concentration as low as 0.5 mu M, at which it functioned similarly with 25 mu M native BSA to impede 25 mu M A beta fibrillation. Cell viability assays also confirmed that the detoxification of 5 mu M BSA-B4 was superior over 25 mu M native BSA by increasing cell viability from 60.6% to 96.0%. Fluorescence quenching study unveiled the decrease of the binding affinity between A beta(42) and the hydrophobic pocket region of BSA-B4, while quartz crystal microbalance experiments demonstrated that the binding constant of BSA-B4 to A beta(42) increased nearly 5 times. Therefore, the increase of electrostatic interactions between BSA-B4 and A beta(42) was the main reason for its high potency. Hence, aminated BSA achieved a conversion of binding way to A beta from a mainly single-site hydrophobic binding to multiregional electrostatic interactions. Similar results were obtained with basified HSA preparations on inhibiting the amyloid formation and cytotoxicity. This work has thus provided new insights into the development of more efficient protein-based inhibitors against A beta fibrillogenesis.

Phytosterols disaggregate bovine serum albumin under the glycation conditions through interacting with its glycation sites and altering its secondary structure elements

The Noncovalent Conjugations of Bovine Serum Albumin with Three Structurally Different Phytosterols Exerted Antiglycation Effects: A Study with AGEs-inhibition, Multispectral, and Docking Investigations

In Vitro Evaluation of Anti-Methylglyoxal/glyoxal Activity of Three Phytosterols Using Glycated Bovine Serum Albumin Models

The Effect of Whey Protein Isolate Hydrolysate on Digestive Properties of Phytosterol

Effects of Degree of Substitution on Stearic Acid-Modified Bletilla Striata Polysaccharides Nanoparticles and Interactions Between Nanoparticles and Bovine Serum Albumin

Phytosterols and Their Derivatives: Potential Health-Promoting Uses Against Lipid Metabolism and Associated Diseases, Mechanism, and Safety Issues.

Inhibitory Effects of Hydroxysafflor Yellow A on the Formation of Advanced Glycation End Products in Vitro.

Polyphenol Binding Disassembles Glycation-Modified Bovine Serum Albumin Amyloid Fibrils

Toward understanding the in vitro anti-amylolytic effects of three structurally different phytosterols in an aqueous medium using multispectral and molecular docking studies

Inhibiting amyloid-like aggregation through bio-conjugation of proteins with polymer surfactant

Polyphenols redirects the self-assembly of serum albumin into hybrid nanostructures

Insight into the Inhibition Effect of Acidulated Serum Albumin on Amyloid Β-Protein Fibrillogenesis and Cytotoxicity.

Comparison of Protective Effects of Phenolic Acids on Protein Glycation of BSA Supported by In Vitro and Docking Studies

Molecular Interaction of Protein-Pigment C-Phycocyanin with Bovine Serum Albumin in a Gomphosis Structure Inhibiting Amyloid Formation.

Effect of 4-mercaptophenylboronic acid functionalized MoS 2 quantum dots on amyloid aggregation of bovine serum albumin

The Digestibility of Hydrothermally-Treated Bovine Serum Albumin Glycated by Glyoxal

Effect of the degree of glycation on the stability and aggregation of bovine serum albumin

Modification of Serum Albumin by High Conversion of Carboxyl to Amino Groups Creates a Potent Inhibitor of Amyloid β-Protein Fibrillogenesis.

The Adsorption Behavior of BSA Protein on Amphiphilic PEG-PS Membrane

Glycation of Bovine Serum Albumin with Monosaccharides Inhibits Heat-Induced Protein Aggregation

Spectroscopic and Molecular Modelling Studies on Glycation Modified Bovine Serum Albumin with Cyanidin-3-o-glucoside